Connection
Konstantinos Arnaoutakis to Pyrazoles
This is a "connection" page, showing publications Konstantinos Arnaoutakis has written about Pyrazoles.
|
|
Connection Strength |
|
|
|
|
|
0.688 |
|
|
|
-
Arnaoutakis K. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2015 02 12; 372(7):683.
Score: 0.466
-
Arnaoutakis K, Wan Y, Elliott J, Young M, Yin Y, Leventakos K, Lin HM, Dimou A. Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLC. Adv Ther. 2024 Aug; 41(8):3217-3231.
Score: 0.223